TOCQUEVILLE ASSET MANAGEMENT L.P. - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$13,409,000
-0.4%
77,595
-33.7%
0.16%
+9.0%
Q4 2014$13,459,000
+4.6%
117,092
+42.2%
0.14%
+1.4%
Q3 2014$12,869,000
+28.9%
82,367
+1.8%
0.14%
+47.4%
Q2 2014$9,983,000
+16.2%
80,933
-2.4%
0.10%
-14.2%
Q1 2014$8,592,000
+21.8%
82,930
+5.8%
0.11%
+18.9%
Q4 2013$7,052,000
+50.9%
78,410
+12.2%
0.10%
+63.8%
Q3 2013$4,672,000
-4.2%
69,861
-5.3%
0.06%
-12.1%
Q2 2013$4,878,00073,7420.07%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders